Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen and aromatase inhibitors

ISSN： 0360-2532

Source： Drug Metabolism Reviews, Vol.42, Iss.1, 2010-02, pp. : 182-194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PARP Inhibitors: Mechanism of Action and Their Potential Role in the Prevention and Treatment of Cancer

By Basu Bristi Sandhu Shahneen K. de Bono Johann S.

Drugs, Vol. 72, Iss. 12, 2012-08 ,pp. : 1579-1590

Adis International

Access to resources Recommend Favorite

Aromatase inhibitors and breast cancer prevention

By Litton Jennifer Keating Arun Banu K Brown Powel H Hortobagyi Gabriel N

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. : 325-331

Informa Healthcare

Access to resources Recommend Favorite

Comparative economic analysis of aromatase inhibitors and tamoxifen in the treatment of hormone-dependent breast cancer

By Miller Lesley-Ann N Roy Anuja Mody Reema Higa Gerald M

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. : 1675-1691

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of aromatase inhibitors

By Hadfield Kristen D Newman William G

Pharmacogenomics, Vol. 13, Iss. 6, 2012-04 ,pp. : 699-707

Future Medicine

Access to resources Recommend Favorite

Tamoxifen Resistant and Refractory Breast Cancer: The Value of Aromatase Inhibitors

By Goss P.E.

Drugs, Vol. 62, Iss. 6, 2002-01 ,pp. : 957-966

Adis International

Access to resources Recommend Favorite